Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2016

1 of 4
Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2016

Summary

‘Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2016’, provides an overview of the Inovio Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Inovio Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Inovio Pharmaceuticals, Inc.
- The report provides overview of Inovio Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Inovio Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Inovio Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Inovio Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Inovio Pharmaceuticals, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Inovio Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Inovio Pharmaceuticals, Inc. Snapshot

Inovio Pharmaceuticals, Inc. Overview

Key Information

Key Facts

Inovio Pharmaceuticals, Inc. - Research and Development Overview

Key Therapeutic Areas

Inovio Pharmaceuticals, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Inovio Pharmaceuticals, Inc. - Pipeline Products Glance

Inovio Pharmaceuticals, Inc. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Inovio Pharmaceuticals, Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Inovio Pharmaceuticals, Inc. - Drug Profiles

VGX-3100

Product Description

Mechanism of Action

R&D Progress

INO-8000

Product Description

Mechanism of Action

R&D Progress

FVH-1

Product Description

Mechanism of Action

R&D Progress

influenza [strain A/H3N2] vaccine

Product Description

Mechanism of Action

R&D Progress

INO-1400

Product Description

Mechanism of Action

R&D Progress

INO-3106

Product Description

Mechanism of Action

R&D Progress

INO-3510

Product Description

Mechanism of Action

R&D Progress

INO-4212

Product Description

Mechanism of Action

R&D Progress

INO-4500

Product Description

Mechanism of Action

R&D Progress

INO-5150

Product Description

Mechanism of Action

R&D Progress

PENNVAX-B

Product Description

Mechanism of Action

R&D Progress

PENNVAX-G

Product Description

Mechanism of Action

R&D Progress

PENNVAX-GP

Product Description

Mechanism of Action

R&D Progress

VGX-3400X

Product Description

Mechanism of Action

R&D Progress

VRC-01

Product Description

Mechanism of Action

R&D Progress

chikungunya vaccine

Product Description

Mechanism of Action

R&D Progress

Clostridium difficile vaccine

Product Description

Mechanism of Action

R&D Progress

dengue [serotypes 1, 2, 3, 4] (tetravalent) vaccine

Product Description

Mechanism of Action

R&D Progress

Gene Therapy for Ebola Virus Infections

Product Description

Mechanism of Action

R&D Progress

influenza [strain A/H7N9] vaccine

Product Description

Mechanism of Action

R&D Progress

INO-5400

Product Description

Mechanism of Action

R&D Progress

MAV-12

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibodies to Inhibit Tyrosinase for Oncology and Immunology

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody for Chikungunya

Product Description

Mechanism of Action

R&D Progress

respiratory syncytial virus vaccine

Product Description

Mechanism of Action

R&D Progress

RSQ-15

Product Description

Mechanism of Action

R&D Progress

Vaccine for Cancer

Product Description

Mechanism of Action

R&D Progress

Vaccines for Neurological Disorders

Product Description

Mechanism of Action

R&D Progress

Inovio Pharmaceuticals, Inc. - Pipeline Analysis

Inovio Pharmaceuticals, Inc. - Pipeline Products by Target

Inovio Pharmaceuticals, Inc. - Pipeline Products by Route of Administration

Inovio Pharmaceuticals, Inc. - Pipeline Products by Molecule Type

Inovio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action

Inovio Pharmaceuticals, Inc. - Recent Pipeline Updates

Inovio Pharmaceuticals, Inc. - Dormant Projects

Inovio Pharmaceuticals, Inc. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

mifepristone

VGX-410C

Inovio Pharmaceuticals, Inc. - Company Statement

Inovio Pharmaceuticals, Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer 73List of Tables

Inovio Pharmaceuticals, Inc., Key Information

Inovio Pharmaceuticals, Inc., Key Facts

Inovio Pharmaceuticals, Inc. - Pipeline by Indication, 2016

Inovio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016

Inovio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016

Inovio Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2016

Inovio Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2016

Inovio Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2016

Inovio Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2016

Inovio Pharmaceuticals, Inc. - Phase II, 2016

Inovio Pharmaceuticals, Inc. - Phase I, 2016

Inovio Pharmaceuticals, Inc. - Preclinical, 2016

Inovio Pharmaceuticals, Inc. - Pipeline by Target, 2016

Inovio Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016

Inovio Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016

Inovio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016

Inovio Pharmaceuticals, Inc. - Recent Pipeline Updates, 2016

Inovio Pharmaceuticals, Inc. - Dormant Developmental Projects,2016

Inovio Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2016

Inovio Pharmaceuticals, Inc., Subsidiaries 71List of Figures

Inovio Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2016

Inovio Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2016

Inovio Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2016

Inovio Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2016

Inovio Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2016

Inovio Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2016

Inovio Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll